Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors.
about
Available and emerging treatments for Parkinson's disease: a reviewParkinson's disease: gene therapiesThe locus coeruleus is directly implicated in L-DOPA-induced dyskinesia in parkinsonian rats: an electrophysiological and behavioural studyThe role of the subthalamic nucleus in L-DOPA induced dyskinesia in 6-hydroxydopamine lesioned ratsOptimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson's diseasePost- versus presynaptic plasticity in L-DOPA-induced dyskinesia.Human amniotic epithelial cells express specific markers of nerve cells and migrate along the nerve fibers in the corpus callosum.Controlled Striatal DOPA Production From a Gene Delivery System in a Rodent Model of Parkinson's Disease.Gene therapy for Parkinson's disease using recombinant adeno-associated viral vectors.Advances in the delivery of treatments for Parkinson's disease.Translational considerations for CNS gene therapy.Continuous DOPA synthesis from a single AAV: dosing and efficacy in models of Parkinson's disease.An update on gene therapy in Parkinson's disease.Gene therapy for Parkinson's disease: state-of-the-art treatments for neurodegenerative disease.Adeno-associated virus vectors and neurological gene therapy.Nanobiomaterials' applications in neurodegenerative diseases.Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesia.Gene therapy for dopamine replacement in Parkinson's disease.Potential cellular and regenerative approaches for the treatment of Parkinson's disease.Cell transplantation and gene therapy in Parkinson's disease.Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis.Levodopa infusion does not decrease the onset of abnormal involuntary movements in parkinsonian rats.
P2860
Q24633444-33265291-C8C2-472D-B2A0-49283EE0C7B6Q26824184-E53E1A0A-F5EB-4ACB-A32F-5C89ECA887ACQ28477041-111A0E16-0A75-49E7-B836-5CF2678233B0Q28482094-99FCDC85-BA22-4304-84B5-863490A0315AQ30493158-7D6026FE-9F98-40F8-8295-01FCCE40FBB5Q33255884-16368858-457E-41A4-88E6-AB2E656CF67DQ35160708-C6911B6D-A886-4B87-83D8-BF12604E12F3Q35582092-540BCB82-B96A-4622-92F5-6B2804457AEBQ36150495-716286D2-A3E9-42CD-AFE1-F509F2D5550DQ36316936-E214114C-9FA0-402A-AD2A-62C896C2A16DQ36739755-85942058-0DA9-4BBD-B2B9-2B2C242F2B89Q36989384-A491FB58-2FB6-42A1-B7CB-006ED8F62C3DQ37863587-49D5B605-B6A7-4842-B0CD-4C58B757E87FQ38112216-2DC569F9-EE6E-45CC-A733-0D2984F24E11Q38190041-4CDBA35B-C51F-4B38-B01C-4A16B7571CDAQ39126802-C0831EDE-2BC9-4E44-9770-FD13A0B657D1Q43109280-AF92D93B-0CF0-4787-AE53-A1F2A6FF537FQ43109283-6E7CBB79-BF41-4DA7-9BD0-0909B6366E01Q43198086-9653761D-D1F3-4174-9EA7-13048299EA30Q44297524-46B26098-0DAE-4320-8998-2978AE86F995Q46294946-1AE3045D-9E3E-4BD6-AFF2-944DB7D78534Q48829185-F35C45EE-297C-4211-A493-53398ABDEBBCQ54328579-3F4F1B44-C988-4C71-903F-C4FC4E00D06E
P2860
Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Reversal of dyskinesias in an ...... A delivery using rAAV vectors.
@ast
Reversal of dyskinesias in an ...... A delivery using rAAV vectors.
@en
Reversal of dyskinesias in an ...... A delivery using rAAV vectors.
@nl
type
label
Reversal of dyskinesias in an ...... A delivery using rAAV vectors.
@ast
Reversal of dyskinesias in an ...... A delivery using rAAV vectors.
@en
Reversal of dyskinesias in an ...... A delivery using rAAV vectors.
@nl
prefLabel
Reversal of dyskinesias in an ...... A delivery using rAAV vectors.
@ast
Reversal of dyskinesias in an ...... A delivery using rAAV vectors.
@en
Reversal of dyskinesias in an ...... A delivery using rAAV vectors.
@nl
P2093
P50
P921
P356
P1433
P1476
Reversal of dyskinesias in an ...... A delivery using rAAV vectors.
@en
P2093
Angela Cenci
Christian Winkler
Deniz Kirik
Nicholas Muzyczka
Ronald J Mandel
P304
P356
10.1093/BRAIN/AWH374
P407
P577
2005-01-19T00:00:00Z